• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CAT和呼吸困难12量表在支气管扩张症和结核毁损肺中的效度和信度

Validity and Reliability of CAT and Dyspnea-12 in Bronchiectasis and Tuberculous Destroyed Lung.

作者信息

Lee Bo Young, Lee Seohyun, Lee Jae Seung, Song Jin Woo, Lee Sang-Do, Jang Seung Hun, Jung Ki-Suck, Hwang Yong Il, Oh Yeon-Mok

机构信息

Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

Tuberc Respir Dis (Seoul). 2012 Jun;72(6):467-74. doi: 10.4046/trd.2012.72.6.467. Epub 2012 Jun 29.

DOI:10.4046/trd.2012.72.6.467
PMID:23101012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3475455/
Abstract

BACKGROUND

The objective of this study was to assess the validity and reliability of the Korean version of chronic obstructive pulmonary disease assessment test (CAT) and Dyspnea-12 Questionnaire for patients with bronchiectasis or tuberculous destroyed lung.

METHODS

For 62 bronchiectasis patients and 37 tuberculous destroyed lung patients, 3 questionnaires including St. George's Respiratory Questionnaires (SGRQ), CAT, and Dyspnea-12 were obtained, in addition to spirometric measurements. To assess the validity of CAT and Dyspnea-12, correlation with SGRQ was evaluated. To assess the reliability of CAT and Dyspnea-12, Cronbach's α coefficient was calculated.

RESULTS

The mean ages of the patients were 60.7±8.3 years in bronchiectasis and 64.4±9.3 years in tuberculous destroyed lung. 46.8% and 54.1% were male, respectively. The SGRQ score was correlated with the score of the Korean version of CAT (r=0.72, p<0.0001) and Dyspnea-12 (r=0.67, p<0.0001) in bronchiectasis patients. The SGRQ score was correlated with the score of CAT (r=0.86, p<0.0001) and Dyspnea-12 (r=0.80, p<0.0001) in tuberculous destroyed lung patients. The Cronbach's α coefficient for the CAT and Dyspnea-12 were 0.84 and 0.90 in bronchiectasis, and 0.88 and 0.94 in tuberculous destroyed lung, respectively.

CONCLUSION

We found that Korean version of CAT and Dyspnea-12 are valid and reliable in patients with tuberculous destroyed lung and bronchiectasis.

摘要

背景

本研究的目的是评估慢性阻塞性肺疾病评估测试(CAT)韩文版和呼吸困难-12问卷在支气管扩张症或结核毁损肺患者中的有效性和可靠性。

方法

对62例支气管扩张症患者和37例结核毁损肺患者,除进行肺功能测量外,还获取了包括圣乔治呼吸问卷(SGRQ)、CAT和呼吸困难-12在内的3份问卷。为评估CAT和呼吸困难-12的有效性,评估了它们与SGRQ的相关性。为评估CAT和呼吸困难-12的可靠性,计算了克朗巴赫α系数。

结果

支气管扩张症患者的平均年龄为60.7±8.3岁,结核毁损肺患者为64.4±9.3岁。男性分别占46.8%和54.1%。在支气管扩张症患者中,SGRQ评分与CAT韩文版评分(r=0.72,p<0.0001)和呼吸困难-12评分(r=0.67,p<0.0001)相关。在结核毁损肺患者中,SGRQ评分与CAT评分(r=0.86,p<0.0001)和呼吸困难-12评分(r=0.80,p<0.0001)相关。支气管扩张症患者中CAT和呼吸困难-12的克朗巴赫α系数分别为0.84和0.90,结核毁损肺患者中分别为0.88和0.94。

结论

我们发现CAT韩文版和呼吸困难-12在结核毁损肺和支气管扩张症患者中是有效且可靠的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/b81120652651/trd-72-467-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/ea632b16ff93/trd-72-467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/329410e5ce44/trd-72-467-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/74ef0a9040bc/trd-72-467-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/b860da6dfef8/trd-72-467-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/76c3739bbde8/trd-72-467-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/be140a29a5b3/trd-72-467-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/717f47dc0a20/trd-72-467-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/b81120652651/trd-72-467-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/ea632b16ff93/trd-72-467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/329410e5ce44/trd-72-467-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/74ef0a9040bc/trd-72-467-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/b860da6dfef8/trd-72-467-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/76c3739bbde8/trd-72-467-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/be140a29a5b3/trd-72-467-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/717f47dc0a20/trd-72-467-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee8/3475455/b81120652651/trd-72-467-g008.jpg

相似文献

1
Validity and Reliability of CAT and Dyspnea-12 in Bronchiectasis and Tuberculous Destroyed Lung.CAT和呼吸困难12量表在支气管扩张症和结核毁损肺中的效度和信度
Tuberc Respir Dis (Seoul). 2012 Jun;72(6):467-74. doi: 10.4046/trd.2012.72.6.467. Epub 2012 Jun 29.
2
The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?慢性阻塞性肺疾病评估测试和圣乔治呼吸问卷:它们在慢性阻塞性肺疾病患者中是否等效?
Int J Chron Obstruct Pulmon Dis. 2016 Jul 7;11:1543-51. doi: 10.2147/COPD.S104947. eCollection 2016.
3
Reliability and validity of the St George's Respiratory Questionnaire for asthma.哮喘圣乔治呼吸问卷的信度和效度。
Int J Tuberc Lung Dis. 2011 Jul;15(7):966-71. doi: 10.5588/ijtld.10.0603.
4
American translation, modification, and validation of the St. George's Respiratory Questionnaire.圣乔治呼吸问卷的美国版翻译、修改及验证
Clin Ther. 2000 Sep;22(9):1121-45. doi: 10.1016/S0149-2918(00)80089-2.
5
Dialectal influence on chronic pulmonary disease assessment test: the reliability and validity study.方言对慢性肺病评估测试的影响:可靠性与有效性研究
Int J Chron Obstruct Pulmon Dis. 2015 Mar 11;10:541-8. doi: 10.2147/COPD.S79041. eCollection 2015.
6
Validation and clinical interpretation of the St George's respiratory questionnaire for COPD (SGRQ-C) after adaptation to Malaysian language and culture, in patients with COPD.验证和临床解读经过马来西亚语言和文化适应性调整后的慢性阻塞性肺疾病圣乔治呼吸问卷(SGRQ-C)在 COPD 患者中的应用。
Health Qual Life Outcomes. 2020 May 13;18(1):138. doi: 10.1186/s12955-020-01393-1.
7
Validation of Korean Version of the London Chest Activity of Daily Living Scale in Patients With Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者中《伦敦胸科日常生活活动量表》韩文版的效度验证
Ann Rehabil Med. 2018 Apr;42(2):329-335. doi: 10.5535/arm.2018.42.2.329. Epub 2018 Apr 30.
8
A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.一项对四项随机临床试验的荟萃分析,以证实日常活动气短(SOBDA)问卷在慢性阻塞性肺疾病中的可靠性和反应性。
Health Qual Life Outcomes. 2015 Oct 31;13:177. doi: 10.1186/s12955-015-0369-3.
9
Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease.评估慢性阻塞性肺疾病评估测试对间质性肺疾病患者健康相关生活质量的测量。
Respirology. 2012 Apr;17(3):506-12. doi: 10.1111/j.1440-1843.2012.02131.x.
10
[Internal consistency and validity of the Spanish version of the St. George's respiratory questionnaire for use in patients with clinically stable bronchiectasis].[圣乔治呼吸问卷西班牙语版在临床稳定支气管扩张症患者中的内部一致性和效度]
Arch Bronconeumol. 2005 Mar;41(3):110-7. doi: 10.1016/s1579-2129(06)60410-2.

引用本文的文献

1
Psychometric Validation of the Simplified Chinese Version of the Dyspnoea-12 Questionnaire for Patients with Primary Lung Cancer.原发性肺癌患者中文版简化版呼吸困难-12问卷的心理测量学验证
Healthcare (Basel). 2025 Jan 20;13(2):201. doi: 10.3390/healthcare13020201.
2
COPD Assessment Test and risk of readmission in patients with bronchiectasis: a prospective cohort study.慢性阻塞性肺疾病评估测试与支气管扩张症患者再入院风险:一项前瞻性队列研究
ERJ Open Res. 2024 Mar 18;10(2). doi: 10.1183/23120541.00867-2023. eCollection 2024 Mar.
3
Evaluation of the Norwegian version of the Dyspnoea-12 questionnaire in patients with COPD.

本文引用的文献

1
Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12.使用描述词对呼吸困难进行量化:呼吸困难-12 的制定和初步测试。
Thorax. 2010 Jan;65(1):21-6. doi: 10.1136/thx.2009.118521. Epub 2009 Dec 8.
2
Development and first validation of the COPD Assessment Test.COPD 评估测试的制定与首次验证。
Eur Respir J. 2009 Sep;34(3):648-54. doi: 10.1183/09031936.00102509.
3
Using the St. George respiratory questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis.
评估 COPD 患者使用挪威语版呼吸困难 12 问卷。
BMJ Open Respir Res. 2022 May;9(1). doi: 10.1136/bmjresp-2022-001262.
4
Evaluating the Effects of Heat-Clearing Traditional Chinese Medicine in Stable Bronchiectasis by a Series of N-of-1 Trials.通过一系列单病例试验评估清热类中药对稳定期支气管扩张症的疗效。
Evid Based Complement Alternat Med. 2022 Jan 17;2022:6690638. doi: 10.1155/2022/6690638. eCollection 2022.
5
Adaptation and validation of the Chinese version of Dyspnoea-12 scale in individuals with chronic obstructive pulmonary disease.呼吸困难 12 量表中文版在慢性阻塞性肺疾病患者中的适应性和验证。
Clin Respir J. 2021 Oct;15(10):1081-1087. doi: 10.1111/crj.13411. Epub 2021 Jul 6.
6
A Series of N-of-1 Trials for Traditional Chinese Medicine Using a Bayesian Method: Study Rationale and Protocol.使用贝叶斯方法的一系列中医药单病例试验:研究原理与方案
Evid Based Complement Alternat Med. 2021 Apr 17;2021:9976770. doi: 10.1155/2021/9976770. eCollection 2021.
7
Validation of the Korean Version of the Bronchiectasis Health Questionnaire.《支气管扩张症健康问卷》韩文版的验证
Tuberc Respir Dis (Seoul). 2020 Jul;83(3):228-233. doi: 10.4046/trd.2020.0025. Epub 2020 Apr 29.
8
The disease burden of bronchiectasis in comparison with chronic obstructive pulmonary disease: a national database study in Korea.支气管扩张症与慢性阻塞性肺疾病的疾病负担比较:韩国一项全国性数据库研究
Ann Transl Med. 2019 Dec;7(23):770. doi: 10.21037/atm.2019.11.55.
9
Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease.呼吸困难 12 量表瑞典语版在伴有心肺疾病的门诊患者中的临床验证。
BMJ Open Respir Res. 2019 Sep 18;6(1):e000418. doi: 10.1136/bmjresp-2019-000418. eCollection 2019.
10
Investigation into the Individualized Treatment of Traditional Chinese Medicine through a Series of N-of-1 Trials.通过一系列单病例随机对照试验对中医个体化治疗的研究。
Evid Based Complement Alternat Med. 2018 Feb 7;2018:5813767. doi: 10.1155/2018/5813767. eCollection 2018.
使用圣乔治呼吸问卷来确定接受治疗的肺结核患者的健康质量。
Chest. 2007 Nov;132(5):1591-8. doi: 10.1378/chest.07-0755. Epub 2007 Sep 21.
4
Pulmonary impairment after tuberculosis.肺结核后的肺功能损害
Chest. 2007 Jun;131(6):1817-24. doi: 10.1378/chest.06-2949. Epub 2007 Mar 30.
5
Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung.结核毁损肺所致慢性气流受限患者的肺功能
Respir Med. 2003 Nov;97(11):1237-42. doi: 10.1016/s0954-6111(03)00255-5.
6
Bronchiectasis.支气管扩张症
N Engl J Med. 2002 May 2;346(18):1383-93. doi: 10.1056/NEJMra012519.
7
Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here?慢性肺病中患者自我评估的健康结果:它们是什么,如何帮助我们,以及我们从这里走向何方?
Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1032-9. doi: 10.1164/ajrccm.156.4.97-02011.
8
Validation of the St. George's Respiratory Questionnaire in bronchiectasis.圣乔治呼吸问卷在支气管扩张症中的效度验证
Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):536-41. doi: 10.1164/ajrccm.156.2.9607083.
9
Quality of life changes in COPD patients treated with salmeterol.使用沙美特罗治疗的慢性阻塞性肺疾病患者的生活质量变化
Am J Respir Crit Care Med. 1997 Apr;155(4):1283-9. doi: 10.1164/ajrccm.155.4.9105068.
10
Measuring health-related quality of life.测量与健康相关的生活质量。
Ann Intern Med. 1993 Apr 15;118(8):622-9. doi: 10.7326/0003-4819-118-8-199304150-00009.